Mercosur-Israel trade deal likely delayed until 2008, officials say

November 29, 2007 22:04


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Mercosur, South America's four-nation trading bloc, failed to clinch a historic free-trade pact with Israel on Thursday after a last-minute disagreement on freeing up trade for certain products, officials said. The deal is now not expected to be completed until next year. It would be the first free-trade agreement for Mercosur, a market of nearly 250 million people covering most of South America, since its creation in 1991. "We had a good meeting and made progress on most remaining issues, but we still have some work to do," said Evandro Didonet, a senior official in Brazil's Foreign Ministry. "If we don't close it in December, we will finish the agreement early in 2008. We are very close." Didonet told The Associated Press that the differences concerned only a "limited number of products." He declined to elaborate.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection